...home of the St. Johns Medical College Community

  • Increase font size
  • Default font size
  • Decrease font size
Home What's New

Whats new

Dr Thomas Chandy starts a new scholarship for new medical students at Saint Johns Medical College through the Alumni Association

E-mail Print PDF
Image result for dr thomas chandy
After some deliberation and soul searching I  decided that this was a suitable time for me to start a scholarship at John's my Alma Mater through my charitable foundation (The Dr. Thomas Chandy Foundation)which is for poor school students. Saint Germains in Bangalore my old primary school has assistance from me in the form of scholarships at this time.My charity also helps poor patients and students of music who cannot afford their fees.

I started a similar scholarship at The Bangalore School of music, where the interest pays for the tuition fees of two or three music students.
Having  had the experience doing this in the past ,when  the Alumni Association got their own 80G I felt this would be something I should do. I chose an individual scholarship as opposed to a group of Johnites contributing as the accountability and transparency would be better for all concerned.

I realized that all the previous scholarships from our days, of Rs 5000 or 10000 (which was a big amount those days) the interest is Rs 450 and 900 respectively per year which today is a miniscule amount due to inflation and much higher fees presently.,I figured that to make a difference a scholarship today should be Rs 6 to 10 lakhs which  why I decided on the 10 lakhs.
Another motivating factor for making this donation was that during my MBBS days at St. Johns I was the youngest of 8 children. My father was First Corporation Commissioner, and later the Registrar of the Karnataka high court. Being on a senior officials government salary, which may have seemed good at the time, he did have some strain in educating and graduating 8 kids, as well as getting 4 girls married. At the present time I see some  teenagers opting out of joining private medical colleges, and joining Government colleges, due to  lack of funds. This scolarship is intended for this group of new students having very high grades, and are bright but their parents are unable to afford the high cost of medial school. I am hoping this  scholarship will help one first MBBS student annually.

I would urge any Johnite that has  the financial means to do so  to also help the students joining Johns who cannot pay the high fees that it now takes to graduate. I hope to do more for needy students in the future

Thomas Chandy
Chairman and Chief of Orthopaedics,
Hosmat Hospital, Bangalore.

Indiana CTSI director Anantha Shekhar selected to lead IU School of Medicine research

E-mail Print PDF

Image result for dr anantha shekhar leadership indiana

News Release 7/29/2015
INDIANAPOLIS -- Anantha Shekhar, M.D., Ph.D., a nationally recognized researcher at the Indiana University School of Medicine and director of Indiana's largest statewide research organization, has been selected to lead the IU School of Medicine's $300 million research enterprise.

Dr. Shekhar, who currently holds several leadership posts at IU and Indiana University Health, will become executive associate dean for research affairs effective Aug. 1, overseeing all research-related activities at the IU School of Medicine. He will be one of six executive associate deans who make up the school's executive leadership team with Dean Jay L. Hess, M.D., Ph.D.

“Anantha has been a tremendous asset not only to the school and IU Health, but to the state through his leadership of the Indiana Clinical and Translational Sciences Institute,” said Jay L. Hess, M.D., Ph.D., dean of the IU School of Medicine and IU vice president for university clinical affairs. “The depth of expertise that Anantha will bring to the role in both clinical and scientific research will further enhance our academic mission and commitment to improving health and patient care.”

"There is huge potential for the IU School of Medicine to be a national leader in research, and great possibilities, working with the health system, to transform the delivery of health care," said Dr. Shekhar, who is associate dean for translational research and Raymond E. Houk Professor of Psychiatry.

Dr. Shekhar has served as the founding director of the Indiana CTSI since 2008, helping create one of the most dynamic and innovative such organizations in the country. The Indiana CTSI, a statewide collaboration that includes Purdue University, the University of Notre Dame and numerous life sciences businesses and community organizations, works to speed the transformation of scientific discoveries in the laboratory into new therapies for patients and new businesses for Indiana.

One of 62 such organizations in country, the Indiana CTSI was funded with an initial five-year, $25 million grant from the National Institutes of Health in 2008. The grant was renewed at $30 million for another five years in 2013.

Dr. Shekhar will continue to direct the operations of the Indiana CTSI, and said he sees the dual roles as an opportunity to provide strategic leadership for the school in collaboration with university, health care and life science business partners across the state.

In addition to his IU School of Medicine and Indiana CTSI roles, Dr. Shekhar serves as associate vice president for university clinical affairs for Indiana University and executive vice president of academic affairs for clinical research at Indiana University Health.

Dr. Shekhar joined the IU School of Medicine faculty in 1989, establishing successful basic science and clinical research programs in neuropsychiatric disorders, notably panic and related anxiety disorders. He has been continuously funded by research grants from the NIH since 1989.

He founded and directed the Neuroscience Clinical Research Center at the Department of Psychiatry from 1997 to 2007. He has initiated several Investigational New Drug applications with the U.S. Food and Drug Administration and has conducted a broad range of clinical trials of new compounds for treatment of anxiety, depression, schizophrenia and bipolar disorder.

Dr. Shekhar has authored more than 200 scientific papers, served as a member of the Board of Scientific Counselors for the National Institute of Mental Health in 2014, and is a tenured member of the Advisory Board for Clinical Research of the National Institutes of Health Clinical Center.

He recently joined as a member of the Advisory Council for the National Center for Advancing Translational Sciences and the Board of Governors of the NIH Cures Acceleration Network.

As executive associate dean for research affairs, Dr. Shekhar will succeed David S. Wilkes, M.D., who recently was named dean of the University of Virginia School of Medicine.

Source: IU School of Medicine


Radiation a risk factor for brain tumors in young people, study finds :Dr Vikram Prabhu

E-mail Print PDF

Image result for dr vikram prabhu'

In people under age 30, radiation is a risk factor for a type of brain tumor called a meningioma, a Loyola University Medical Center study has found.

Researchers analyzed records of 35 patients who were diagnosed with meningiomas before age 30. Five had been exposed to ionizing radiation earlier in their lives. They include two patients who received radiation for leukemia at ages 5 and 6; one who received radiation at age 3 for a brain tumor known as a medulloblastoma; and one who received radiation for an earlier skull base tumor that appeared to be a meningioma. The fifth patient had been exposed at age 9 to radiation from the Chernobyl nuclear power plant disaster in Ukraine. Twenty years later, he was diagnosed with a meningioma.

In the five patients, the average latency period for the tumors was 23.5 years.

The study was published in the online journal Neuroscience Discovery.

"The results of this preliminary study have prompted us to look closely at radiation's effects on the brain," said Loyola neurosurgeon Vikram Prabhu, MD, first author of the study. Dr. Prabhu specializes in treating brain tumors.

A meningioma is a tumor, usually benign, that arises from the meninges -- the membranes that surround the brain and spinal cord. Meningiomas comprise about one-third of all primary brain tumors, but are rare in children and young adults. It is one of the commonest brain tumors treated at Loyola by Dr. Prabhu and his team. They are doing a follow-up study on patients of all ages who have been treated at Loyola for meningiomas. In collaboration with Dr. Omer Iqbal, from the Department of Pathology, they are analyzing the genetics and biology of tumor samples to find how they differ from samples of tumors not linked to radiation.

Loyola oncologist Kevin Barton, MD, a co-author of the study, said: "It is important to compare and contrast these post-radiation meningiomas with de novo meningiomas, both clinically and biologically, in order to further define optimal therapy."

Researchers so far have identified 14 meningioma patients who were exposed to radiation earlier in their lives. They include three patients who were exposed to Chernobyl radiation and 11 patients who received therapeutic radiation for such conditions as leukemia, medulloblastoma tumors and fungal infections of the scalp.

Dr. Edward Melian, a radiation oncologist at Loyola and co-author of the study, said patients generally have done very well with radiation treatments. "Although we have identified radiation as a risk factor for meningiomas, radiation remains an important part of the treatment regimen for certain lesions, and is helping us obtain good results for our patients."

Dr. Prabhu said physicians have become more judicious in using radiation for therapeutic purposes. For example, radiation no longer is used to treat fungal scalp infections.

"We have become more aware of the tumor-inducing properties of radiation," Dr. Prabhu said.

People who have been exposed to large doses of radiation to the head face a small risk of later developing brain tumors. If such a person experiences symptoms associated with brain tumors, including headaches, seizures, vomiting and blurry vision, he or she should see a doctor, Dr. Prabhu said.

Dr. Prabhu is a professor in the Department of Neurological Surgery at Loyola University Chicago Stritch School of Medicine. Dr. Melian is an associate professor in the departments of Radiation Oncology and Neurological Surgery. Dr. Barton is an associate professor in the Division of Hematology/Oncology. Other co-authors are Loyola biostatistician Rong Guo, PhD; Douglas Anderson, MD, a professor in the Department of Neurological Surgery; and Edward Perry, MD, who completed a residency in neurological surgery at Loyola.



The study is titled "Intracranial meningiomas in individuals under the age of 30; Analysis of risk factors, histopathology and the recurrence rate."


Painting By Dr Danny George

E-mail Print PDF

Santorini - Acrylic on Canvas.

For me this is about keeping my word. I did rekindle an old habit at the turn of New Year this year. Now, 6 months and 2 exams later, I finally managed to finish this painting. 

Santorini is an island off the mainland of Greece. This picture is iconic. I set about doing this painting because of its striking colours - brilliant blue and white. I thought it would be simple, just blue and white, right? But it became an arduous task trying to get all 50 shades of white correct! Then came a moment when the technique crystallized and from then on, it was rather smooth sailing. Added a few details for the roving eye to pick up.

And thus was completed my first painting in 8 years! 


High Mast Floodlights dedicated by Director

E-mail Print PDF

Father Paul Parathazham, Director of the St John’s National Academy of Health Sciences dedicated the high mast floodlights installed on the Sarjapur Road in front of St John’s Hospital on Monday evening in presence of residents, representatives of various RWAs in Koramangala and adjoining areas as well as officials from the BBMP Streetlight wing. Later sweets were distributed.
Similarly the newly installed floodlights were switched on by former Block Congress President Narayana Gowda at the Beauty Spot Park in Koramangala 5th Block.
Koramangala Ward President Govardhan Reddy, Congress leaders Radhakrishna, Ashok Reddy, Raghuram Reddy, Koramangala 4th Block RWA President G M Shetty, Secretary Cherian, Ejipura New Extension Residents’ Association (ENERA) President Ravindra Kumar, Koramangala 3rd Block RWA Secretary Reggie Thomas, Nitin Seshadri, Dr Umeshwara from 5th Block, Narayana Gowda, Venkatesh Jetty, Kishan Naik, Krishna, from Jakkasandra Extension, Murugesh from 7th Block, BBMP official Sandeep, Kudremukh Colony residents and others were present


Page 5 of 87